4//SEC Filing
CLINICHEM DEVELOPMENT INC 4
Accession 0000893750-00-000350
CIK 0001054396other
Filed
Aug 7, 8:00 PM ET
Accepted
—
Size
67.0 KB
Accession
0000893750-00-000350
Insider Transaction Report
Form 4
Fresne, Donald C.
10% Owner
Transactions
- Sale
Class A Common Shares
2000-07-28$9.63/sh−396,274$3,816,119
Footnotes (2)
- [1]At the time of disposition, these 396,274 shares were held of record by the Reporting Person on behalf of its parent company, Glaxo Wellcome International B.V. Pursuant to Rule 16a-1(a)
- [4]promulgated under the Securities Exchange Act of 1934, as amended, the Reporting Person herein states that this filing shall not be deemed an admission that he or it is the beneficial owner of any of the securities covered by this Statement. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. GLAXO WELLCOME INC. August 7, 2000 - --------------------------------------------- --------------- By: /s/ Patrick M. McGrade Date - -------------------------------------- Name: Patrick M. McGrade Title: Assistant Corporate Secretary **
Documents
Issuer
CLINICHEM DEVELOPMENT INC
CIK 0001054396
Entity typeother
Related Parties
1- filerCIK 0001054396
Filing Metadata
- Form type
- 4
- Filed
- Aug 7, 8:00 PM ET
- Size
- 67.0 KB